| 华法林相关性脑出血 |
| |
| 引用本文： | 王晔,郭大文,王德生. 华法林相关性脑出血[J]. 国际脑血管病杂志, 2010, 18(6). DOI: 10.3760/cma.j.issn.1673-4165.2010.06.004 |
| |
| 作者姓名： | 王晔 郭大文 王德生 |
| |
| 作者单位： | 沈阳军区总医院神经内科,110015;哈尔滨医科大学第一临床医学院神经内科,150001 |
| |
| 基金项目： | 沈阳军区总医院院课题 |
| |
| 摘 要： | 华法林相关性脑出血发病率逐渐升高,早期病死率高达50%.危险因素包括高龄、国际标准化比率>3.5、高血压、卒中史、白质疏松、淀粉样脑血管病、伴随抗血小板治疗等.预后较差,尚无最佳治疗.
|
| 关 键 词： | 脑出血 华法林 抗凝药 凝血因子类 因子Ⅶa 维生素 K |
Warfarin-associated intracerebral hemorrhage |
| |
| WANG Ye,GUO Da-wen,WANG De-sheng. Warfarin-associated intracerebral hemorrhage[J]. International Journal of Cerebrovascular Diseases, 2010, 18(6). DOI: 10.3760/cma.j.issn.1673-4165.2010.06.004 |
| |
| Authors: | WANG Ye GUO Da-wen WANG De-sheng |
| |
| Abstract: | The incidence of warfarin-associated intracerebral hemorrhage is increasing gradually. Its early mortality is as high as 50%. The risk factors include advanced age, international normalized ratio > 3.5, hypertension, previous stroke, leukoaraiosis, cerebral amyloid angiopathy, and concomitant antiplatelet therapy, etc. Its prognosis was poor and there is no optimal treatment. |
| |
| Keywords: | Cerebral hemorrhage Warfarin Anticoagulants Blood coagulation factors Factor Ⅶa Vitamin K |
| 本文献已被 万方数据 等数据库收录！ |
|
